PMID: 42168250

RRM2 as a biomarker and therapeutic target in letrozole resistant estrogen receptor positive breast cancer.

Hung Wan-Yu, Huang Shih-Chun, Chen Shou-Tung, Lin Chi-Chen, Hou Ming-Hon, Breast Cancer Genomics and Therapy Consortium

Scientific reports · 2026

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.